Clinical Trials Browser

INDUSTRY × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Ipilimumab × Clear all

NCT00732186 2016-02-17

Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia

Phase 1 Withdrawn

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive